LENSAR Return On Equity from 2010 to 2025
| LNSR Stock | USD 14.17 0.07 0.49% |
Check LENSAR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LENSAR's main balance sheet or income statement drivers, such as , as well as many indicators such as . LENSAR financial statements analysis is a perfect complement when working with LENSAR Valuation or Volatility modules.
LENSAR |
About LENSAR Financial Statements
LENSAR shareholders use historical fundamental indicators, such as Return On Equity, to determine how well the company is positioned to perform in the future. Although LENSAR investors may analyze each financial statement separately, they are all interrelated. The changes in LENSAR's assets and liabilities, for example, are also reflected in the revenues and expenses on on LENSAR's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida. LENSAR operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 110 people.
Pair Trading with LENSAR
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if LENSAR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LENSAR will appreciate offsetting losses from the drop in the long position's value.Moving together with LENSAR Stock
Moving against LENSAR Stock
| 0.75 | HOLX | Hologic | PairCorr |
| 0.75 | ELEV | Elevation Oncology | PairCorr |
| 0.73 | VINC | Vincerx Pharma Earnings Call This Week | PairCorr |
| 0.72 | SSKN | STRATA Skin Sciences | PairCorr |
| 0.66 | INFU | InfuSystems Holdings | PairCorr |
The ability to find closely correlated positions to LENSAR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace LENSAR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back LENSAR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling LENSAR Inc to buy it.
The correlation of LENSAR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as LENSAR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if LENSAR Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for LENSAR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for LENSAR Stock Analysis
When running LENSAR's price analysis, check to measure LENSAR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENSAR is operating at the current time. Most of LENSAR's value examination focuses on studying past and present price action to predict the probability of LENSAR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENSAR's price. Additionally, you may evaluate how the addition of LENSAR to your portfolios can decrease your overall portfolio volatility.